|Robert B. Jones|
President & Chief Executive Officer
Robert B. Jones has been a member of our Board of Directors since July 2011. Mr. Jones has been our President & CEO since July 2011 and served in that capacity on an interim basis since May 2011 after the passing of Andy Reddick in April 2011. Bob previously served as Senior Vice President and Chief Operating Officer since he joined Acura in April 2008. From May, 2003 to March, 2008, Mr. Jones served first as the Vice President, Finance and then as Vice President, Strategy and Business Analysis of Adolor Corporation. From November 2000 to May, 2003 he served as Vice President, Finance and then as Chief Operating Officer of Opt-E-Script, Inc., a privately held personalized medicine company where Mr. Jones was responsible for all commercialization activities. Prior to that, Mr. Jones was Vice President, Sales and Marketing for Purepac Pharmaceutical Company. Mr. Jones received his M.B.A. from the University of North Carolina and a B.S. from Cornell University.
|William G. Skelly|
|Bruce F. "Toby" Wesson|
= Chair = Member
Stock transaction information provided by EDGAR Online. Acura Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.